I should first like to pay particular tribute to Dr. Kempe and to the University of Colorado School of Medicine for having brought together into this International Conference such a tremendous amount of information concerning measles, and also for giving us the opportunity of paying such a magnificent and well-deserved tribute to Dr. Enders.
I think it would be worthwhile to come round the circle, as it were, to certain items Dr. Wilson reviewed at the very beginning of this conference, namely, those areas that we need to consider in measuring our success or failure, areas which bear directly on the practical aspects of measles immunization in the United States and throughout the world. These were harmlessness, lack of reaction, acceptance by parents and physicians alike, the ease of giving the vaccine, its efficacy, and the herd immunity. In addition to these points Dr. Wilson mentioned, it is well worthwhile
STOKES J. Future of Measles Vaccine in the U.S.A. Part I. Am J Dis Child. 1962;103(3):525–528. doi:10.1001/archpedi.1962.02080020537081
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: